Literature DB >> 24907670

Insights into the population structure of Mycobacterium tuberculosis using spoligotyping and RDRio in a southeastern Brazilian prison unit.

Fé Dagmar Huber1, Alexandra Sánchez2, Harrison Magdinier Gomes3, Sidra Vasconcellos3, Véronique Massari4, Angela Barreto5, Vanderci Cesconi2, Silvia Maria de Almeida Machado1, Michel K Gomgnimbou6, Christophe Sola7, Bernard Larouzé8, Philip Noel Suffys3, Maria Helena Féres Saad9.   

Abstract

Tuberculosis (TB) is still a serious public health problem, continuing to be an important threat for confined populations. We used spoligotyping to estimate the genotypic clades of Mycobacterium tuberculosis isolates from inmates in two blocks in a southeastern Brazilian prison unit, with TB incidence rate of 8185/100.000. The Latin American Mediterranean (LAM) clade is well represented in the country, and the LAM specific molecular markers, RD(Rio) large sequence polymorphism and the SNP on the Rv3062 [ligB(1212)], were used to characterize spoligotype signatures from prison isolates. Typing of RD(Rio) and ligB increase LAM clade from 66.7% (n=72/108) to 69.4% (n=75). The LAM2 SIT17 (n=23) and SIT179 (n=12) signatures comprised one third of all isolates, followed by Haarlem (11.5%, n=12), T (8.7%, n=9) and X (5.7%, n=6) clades. Strains with unknown signatures represented 5.5% (n=6), and four (3.7%) did not match any lineage. We observed RD(Rio) among 64 (59.2%) isolates, and 54 (50%) were of the LAM clade. In particular, the LAM2/RD(Rio) sub-lineage was significantly associated with clustering (p=0.02) and its frequency was higher (32%) when compared to that of the previous general TB cases in RJ (4.29%). Overall cluster frequency defined by spoligotyping/IS6110-RFLP was 62%. The two evolutionary markers helped to evaluate some LAM signature misconceptions and demonstrate that LAM2/RD(Rio) was found with high frequency, hitherto being unnoticed. All these data, allied to high clustering, imply that public health measures to minimize the escalation of TB in prison is essential, and both spoligotyping as well as RD(Rio) would be useful tools to monitor the effects of the measures with respect to M. tuberculosis lineage variation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Large-sequence polymorphisms; M. tuberculosis; Prison; Rv3062 (LigB); Spoligotyping; Tuberculosis

Mesh:

Year:  2014        PMID: 24907670     DOI: 10.1016/j.meegid.2014.05.031

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  4 in total

1.  Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.

Authors:  Sita Sirisha Madugula; Selvaraman Nagamani; Esther Jamir; Lipsa Priyadarsinee; G Narahari Sastry
Journal:  Mol Divers       Date:  2021-09-01       Impact factor: 2.943

Review 2.  Tuberculosis Genetic Epidemiology: A Latin American Perspective.

Authors:  Marc Woodman; Ilsa L Haeusler; Louis Grandjean
Journal:  Genes (Basel)       Date:  2019-01-16       Impact factor: 4.096

3.  Population structure and genetic diversity of Mycobacterium tuberculosis in Ecuador.

Authors:  Daniel Garzon-Chavez; Miguel Angel Garcia-Bereguiain; Carlos Mora-Pinargote; Juan Carlos Granda-Pardo; Margarita Leon-Benitez; Greta Franco-Sotomayor; Gabriel Trueba; Jacobus H de Waard
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

Review 4.  Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review.

Authors:  Emilyn Costa Conceição; Richard Steiner Salvato; Karen Machado Gomes; Arthur Emil Dos Santos Guimarães; Marília Lima da Conceição; Ricardo José de Paula Souza E Guimarães; Abhinav Sharma; Ismari Perini Furlaneto; Regina Bones Barcellos; Valdes Roberto Bollela; Lívia Maria Pala Anselmo; Maria Carolina Sisco; Cristina Viana Niero; Lucilaine Ferrazoli; Guislaine Refrégier; Maria Cristina da Silva Lourenço; Harrison Magdinier Gomes; Artemir Coelho de Brito; Marcos Catanho; Rafael Silva Duarte; Philip Noel Suffys; Karla Valéria Batista Lima
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-03-15       Impact factor: 2.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.